{
    "root": "313e65c4-3402-27b4-e063-6294a90a8134",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Colchicine",
    "value": "20250326",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C RED NO. 3",
            "code": "PN2ZH5LOQY"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "COLCHICINE",
            "code": "SML2Y3J35T"
        }
    ],
    "indications": "Colchicine capsules are indicated for prophylaxis of gout flares in adults.\n                  \n                     Limitations of Use:\n\n \n                  The safety and effectiveness of colchicine capsules for acute treatment of gout flares during prophylaxis has not been studied.\n                  Colchicine capsules are not an analgesic medication and should not be used to treat pain from other causes.",
    "contraindications": "The recommended dosage is 0.6 mg (one capsule) once or twice daily ( 2 ). Maximum dose 1.2 mg/day. Colchicine capsules are administered orally, without regard to meals ( 2 ).",
    "warningsAndPrecautions": null,
    "adverseReactions": "Patients with renal or hepatic impairment should not be given colchicine capsules with drugs that inhibit both P-glycoprotein and CYP3A4 inhibitors\n \n  [see\n  \n   Drug Interactions\n                        (7)]\n \n  . Combining these dual inhibitors with colchicine in patients with renal or hepatic impairment has resulted in life-threatening or fatal colchicine toxicity.\n\n \n                  Patients with both renal and hepatic impairment should not be given colchicine capsules."
}